Please provide your email address to receive an email when new articles are posted on . Assessing apolipoprotein E genotypes and baseline MRI data are key to identifying higher risk patients. ARIA ...
The trial missed the primary endpoint of slowing cognitive decline in the overall study population. Topline results were announced from a phase 3 trial evaluating valiltramiprosate (ALZ-801) in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback